Abstract
LTB4, a proinflammatory lipid mediator generated from arachidonic acid through the action of 5-lipoxygenase, has been known for over two decades and is implicated in a wide variety of inflammatory disorders. BLT1, a G-protein-coupled receptor, has recently been identified as a high affinity receptor specific for LTB4. Recent studies in allergen-induced airway hyperresponsiveness and inflammation using mice lacking BLT1 have shown crucial new roles for leukotriene B4 and BLT1 in Th2 cytokine IL-13 production from lung T cells and recruitment of antigen-specific effector CD8+ T cells, suggesting novel mechanisms for their actions. The leukotriene B4-BLT1 pathway is an important target for the treatment of bronchial asthma.
Original language | English |
---|---|
Pages (from-to) | 91-97 |
Number of pages | 7 |
Journal | Allergology International |
Volume | 55 |
Issue number | 2 |
DOIs | |
Publication status | Published - Jun 2006 |
Externally published | Yes |
Keywords
- Airway responsiveness
- Cytokines
- Lipid mediators
- Lung inflammation
- T cells
ASJC Scopus subject areas
- Immunology and Allergy